University of Crete (UOC)
Κυκλοφορούντα ενδοθηλιακά κύτταρα και μεταβολικές διαταραχές σε παιδιά, εφήβους και νεαρούς ενήλικες, που έχουν ιαθεί από νεοπλασία της παιδικής ηλικίας
Abstract
dc:descriptionBackground: Circulating endothelial progenitor cells (cEPCs) are known to have an active role in maintaining healthy vessel anatomy and function. The purpose of the present study was to quantify cEPCs in childhood cancer survivors after treatment completion and evaluate possible associations of their levels with metabolic disorders. Methods: Circulating EPCs isolated from peripheral blood samples from 383 children and adolescents cancer survivors diagnosed with Acute Lymphoblastic Leukemia(ALL), lymphomas or solid tumors(ST) were quantified 1 year, 3 years and more than 3 years after treatment completion using flow cytometry. Their levels were compared to 200 healthy controls and multivariate logistic regression analysis was applied to seek correlations with metabolic disorders including hypertension, obesity, hyperglycemia, and dyslipidemia. Results: The levels of CD34+/CD133+/VEGFR+ and CD34+/VEGFR+ cEPCs were significantly higher in children treated for solid tumors and lymphomas compared to ALL group. Compared to controls, both cEPCs populations were found increased in patients treated for ST (CD34+/CD133+/VEGFR+ p:0.0049, CD34+/VEGFR+ p:0.0001). Declining trends of CD34+/VEGFR+ and CD34+/CD133+/VEGFR+ levels were observed in patients treated forsolid tumors and lymphomas during the first 3 years after treatment while an increasing trend was observed in ALL patients (p:0.01). Three years after treatment completion, all groups had cEPCs levels comparable with the control group. By multivariate regression analysis, no significant differences were observed in children with metabolic disorders including hypertension, obesity, hyperglycemia, and dyslipidemia. Conclusion: Significant differences in cEPCs levels were observed in childhood cancer survivors during the first year after treatment completion which were comparable to healthy controls after three years post-treatment.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Athanasopoulos, Emmanouil
- Αθανασόπουλος, Εμμανουήλ
Subjects
dc:subject × 13- Κυκλοφορούντα Ενδοθηλιακά Κύτταρα
- Νεοπλασίες
- Παιδιά
- Έφηβοι
- Ίαση
- Childhood cancer survivors
- Circulating endothelial progenitor cells
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Παιδιατρική, Νεογνολογία και Υγεία του παιδιού
- Clinical Medicine
- Medical and Health Sciences
- Pediatrics, Perinatology and Child Health
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60889